Barbara Biere

ORCID: 0000-0001-6988-3735
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Respiratory viral infections research
  • Influenza Virus Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • Pneumonia and Respiratory Infections
  • Viral gastroenteritis research and epidemiology
  • Health and Medical Studies
  • Biosensors and Analytical Detection
  • COVID-19 epidemiological studies
  • Animal Disease Management and Epidemiology
  • COVID-19 Clinical Research Studies
  • Tracheal and airway disorders
  • COVID-19 diagnosis using AI
  • Animal Virus Infections Studies
  • Bacteriophages and microbial interactions
  • Congenital Diaphragmatic Hernia Studies
  • Advanced biosensing and bioanalysis techniques
  • Virus-based gene therapy research
  • Respiratory Support and Mechanisms
  • Travel-related health issues
  • Infectious Encephalopathies and Encephalitis
  • Viral Infectious Diseases and Gene Expression in Insects
  • Disaster Response and Management
  • vaccines and immunoinformatics approaches
  • Cystic Fibrosis Research Advances

Robert Koch Institute
2015-2024

Hospital Clínico Universitario de Valladolid
2017

Leipzig University
2008

During the initial COVID-19 response, Germany's Federal Government implemented several nonpharmaceutical interventions (NPIs) that were instrumental in suppressing early exponential spread of SARS-CoV-2. NPI effect on transmission other respiratory viruses has not been examined at national level thus far.

10.1016/j.lanepe.2021.100112 article EN cc-by The Lancet Regional Health - Europe 2021-06-07

Background Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic affected respiratory syncytial virus (RSV) circulation worldwide. Aim To describe, for children aged < 5 years, 2021 and 2022/23 RSV seasons in Germany. Methods Through data 16,754 specimens from outpatient sentinel surveillance, we investigated seasonality, circulating lineages, children’s age distributions 2022/23. Available information about disease severity hospital surveillance was analysed patients with...

10.2807/1560-7917.es.2024.29.13.2300465 article EN cc-by Eurosurveillance 2024-03-28

Respiratory viruses are a cause of upper respiratory tract infections (URTI), but can be associated with severe lower (LRTI) in immunocompromised patients. The objective this study was to investigate the genetic variability influenza virus, parainfluenza virus and syncytial (RSV) duration viral shedding hematological Nasopharyngeal swabs from patients were screened for influenza, RSV on admission as well development symptoms. Consecutive collected until clearance. Out 672 tested patients,...

10.1371/journal.pone.0148258 article EN cc-by PLoS ONE 2016-02-11

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilises the angiotensin-converting enzyme (ACE2) transmembrane peptidase as cellular entry receptor. However, whether SARS-CoV-2 in alveolar compartment is strictly ACE2-dependent and to what extent virus-induced tissue damage and/or direct immune activation determines early pathogenesis still elusive.Spectral microscopy, single-cell/-nucleus RNA sequencing or ACE2 "gain-of-function" experiments were applied infected human lung...

10.1183/13993003.02725-2021 article EN cc-by-nc European Respiratory Journal 2022-06-21

ABSTRACT Since the 1970s, influenza B viruses have diverged into two antigenically distinct virus lineages called Yamagata and Victoria lineages. We present first real-time PCR assay for lineage differentiation to supplement classical antigenic analyses. The was successfully applied 310 primary samples collected in Germany from 2007 2009.

10.1128/jcm.02116-09 article EN Journal of Clinical Microbiology 2010-01-28

Essential epidemiologic and virologic parameters must be measured to provide evidence for policy/public health recommendations mathematical modeling concerning novel influenza A/H1N1 virus (NIV) infections. Therefore, from April through August of 2009, the authors collected nasopharyngeal specimens information on antiviral medication symptoms households with NIV infection a daily basis in Germany. Specimens were analyzed quantitatively by using reverse transcriptase-polymerase chain...

10.1093/aje/kwq071 article EN American Journal of Epidemiology 2010-05-03

The reliable detection of SARS-CoV-2 has become one the most important contributions to COVID-19 crisis management. With publication first sequences SARS-CoV-2, several diagnostic PCR assays have been developed and published. In addition in-house market was flooded with numerous commercially available ready-to-use kits, both approaches showing alarming shortages in reagent supply.

10.1186/s12985-021-01559-3 article EN cc-by Virology Journal 2021-06-02

Background The current spread of pandemic influenza A(H1N1)v virus necessitates an intensified surveillance infections worldwide. So far, in many laboratories routine diagnostics were limited to generic detection only. To provide interested with real-time PCR assays for type and subtype identification, we present a bundle which any human A B can be easily identified, including the virus. Principal Findings show optimal performance characteristics their validation on plasmids containing...

10.1371/journal.pone.0009966 article EN cc-by PLoS ONE 2010-04-01

Based on our national outpatient sentinel surveillance, we have developed a novel approach to determine respiratory syncytial virus (RSV) epidemic seasons in Germany by using RSV positivity rate and its lower limit of 95% confidence interval. This method was evaluated retrospectively nine seasons, it is also well-suited describe off-season circulation near real time as observed for 2020/21 2021/22 during the COVID-19 pandemic. Prospective application crucial importance enable timely actions...

10.1111/irv.12996 article EN cc-by Influenza and Other Respiratory Viruses 2022-04-29

Abstract Background Comprehensive pathogen genomic surveillance represents a powerful tool to complement and advance precision vaccinology. The emergence of the Alpha variant in December 2020 resulting efforts track spread this other severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants concern led an expansion sequencing activities Germany. Methods At Robert Koch Institute (RKI), German National Public Health, we established Integrated Molecular Surveillance for SARS-CoV-2...

10.1093/cid/ciac399 article EN cc-by-nc-nd Clinical Infectious Diseases 2022-06-24

Before the COVID-19 pandemic, acute respiratory infections (ARIs) in children were mainly characterised by three pathogens: syncytial viruses (RSV), influenza and rhinoviruses. The impact of pandemic measures taken Germany (especially until end 2021) on incidence ARI adolescents aged 0 to 14 years pathogens causing them has not yet been comprehensively analysed.The evaluation is based data from population-based, virological hospital-based surveillance instruments up 2022.After onset early...

10.25646/11437 article EN PubMed 2023-06-01

Respiratory viral infections may have different impacts ranging from infection without symptoms to severe disease or even death though the reasons are not well characterized. A patient (age group 5-15 years) displaying of hemolytic uremic syndrome died one day after hospitalization. qPCR, next generation sequencing, virus isolation, antigenic characterization, resistance analysis was performed and replication kinetics in well-differentiated airway cells were determined. Autopsy revealed...

10.1016/j.ijmm.2024.151598 article EN cc-by International Journal of Medical Microbiology 2024-01-11

Acute lower respiratory tract infection (ALRI) is a leading cause of childhood morbidity and mortality in developing countries. Globally, human syncytial virus (HRSV) the most common pathogen ALRI infants children. However, age-stratified HRSV disease burden data are largely absent from Africa, which key gap informing an evidence-based recommendation for introduction vaccine by WHO.

10.1371/journal.pone.0203788 article EN cc-by PLoS ONE 2018-09-10
Charlotte Lanièce Delaunay Clara Mazagatos Iván Martínez‐Baz Gergő Túri Luise Goerlitz and 95 more Lisa Domegan Adam Meijer Ana Paula Rodrigues Noémie Sève Maja Ilić Neus Latorre‐Margalef Mihaela Lazăr Marine Maurel Aryse Martins Melo Blanca Andreu Ivorra Itziar Casado J Horváth Silke Buda Charlene Bennett Marit de Lange Raquel Guiomar Vincent Enouf Ivan Mlinarić Tove Samuelsson Hagey Sorin Dinu Mercedes Rumayor Jesús Castilla Beatrix Oroszi Ralf Dürrwald Joan O’Donnell Mariëtte Hooiveld Verónica Gómez Alessandra Falchi Sanja Filipović Lena Dillner Rodica Popescu Sabrina Bacci Marlena Kaczmarek Esther Kissling Virtudes Gallardo García Esteban Perez Morilla Irene Pedrosa Corral Miriam García Vázquez Ana Milagro Ana Fernández Ibáñez Mario Margolles Martins Jaume Giménez Durán Bartolomé Sastre Palou Carla López Causapé Luis Javier Viloria Raymundo Tomás Vega Alonso Ana Ordax Díez José Eugenio Lozano Alonso Silvia Rojo Bello Jacobo Mendioroz Luca Basile Ana Isabel Martínez Mateo Carlota Ruiz de Porras Alba Moya Garcés Ma Ángeles Marcos A. López Maside Francesc Botella Quijal Maite Miralles Espi Cristina Andreu Salete María del Carmen García Rodríguez J. Linares Luis García Comas Ma Isabel Barranco María‐Dolores Chirlaque Antonio Moreno Docón Violeta Ramos Marín Daniel Castrillejo Atanasio Gómez Anés Amparo Larrauro Gloria Pérez‐Gimeno Marcos Lozano Álvarez Lorena Vega Silvia Galindo Tania Puma Susana Monge Francisco Pozo Inmaculada Casas Virginia Martin Sonia Vázquez‐Morón Aitziber Echeverría Camino Trobajo‐Sanmartín Manuel García Cenoz Guillermo Ezpeleta Carmen Ezpeleta Ana Navascués Katalin Krisztalovics Krisztina Mucsányiné Juhász Katalin Kristóf Ute Preuß Marianne Wedde Barbara Biere Janine Reiche Djin‐Ye Oh Adele McKenna Jeff Connell

Importance In the context of emerging SARS-CoV-2 variants or lineages and new vaccines, it is key to accurately monitor COVID-19 vaccine effectiveness (CVE) inform vaccination campaigns. Objective To estimate vaccines administered in autumn winter 2022 2023 against symptomatic infection (with all circulating viruses XBB lineage particular) among people aged 60 years older Europe, compare different CVE approaches across exposed reference groups used. Design, Setting, Participants This...

10.1001/jamanetworkopen.2024.19258 article EN cc-by-nc-nd JAMA Network Open 2024-07-01

Pigeon circovirus (PiCV) infection and young pigeon disease syndrome (YPDS), associated with high morbidity mortality, have been recognized in racing pigeons from large portions of Central Europe. There exist a number data indicating that YPDS is consequence PiCV subsequent immunosuppression. In order to prove be one the crucial factors YPDS, an experimental was performed under controlled conditions. Twenty-four domestic (Columba livia forma domestica) were divided into two groups 12 each;...

10.1637/8188-120407-reg article ES Avian Diseases 2008-09-01

The corona virus disease-2019 (COVID-19) pandemic began in Wuhan, China, and quickly spread around the world. overlapped with two consecutive influenza seasons (2019/2020 2020/2021). This provided opportunity to study community circulation of viruses severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) outpatients infections during these within Bavarian Influenza Sentinel (BIS) Bavaria, Germany. From September March, oropharyngeal swabs collected at BIS were analysed for SARS-CoV-2...

10.1017/s0950268821002296 article EN cc-by-nc-nd Epidemiology and Infection 2021-01-01

A zoonotic A/sw/H1 av N1 1C.2.2 influenza virus infection was detected in a German child that presented with influenza-like illness, including high fever. There history of close contact pigs 3 days before symptom onset. The recovered within days. No other transmissions were observed. Serological investigations the isolate revealed cross-reactions ferret antisera against A(H1N1)pdm09 virus, indicating closer antigenic relationship than former seasonal H1N1 viruses.

10.2807/1560-7917.es.2020.25.42.2001638 article EN cc-by Eurosurveillance 2020-10-22

IntroductionRecent data on influenza C virus indicate a possible higher clinical impact in specified patient populations than previously thought.AimWe aimed to investigate circulation Germany.MethodsA total of 1,588 samples from 0 4 year-old children presenting as outpatients with influenza-like illness (ILI) or acute respiratory infection were analysed retrospectively. The represented subset all the German national surveillance system for this age group 2012-14. presence was investigated by...

10.2807/1560-7917.es.2019.24.10.1800174 article EN cc-by Eurosurveillance 2019-03-07

Human parainfluenza viruses (HPIVs) are important causes of respiratory illness, especially in young children. However, surveillance for HPIV is rarely performed continuously, and national-level epidemiologic genetic data scarce. Within the German sentinel system, to monitor acute infections (ARI), 4463 specimens collected from outpatients < 5 years age between October 2015 September 2019 were retrospectively screened 1-4 using real-time PCR. was identified 459 (10%) samples. HPIV-3 most...

10.3390/microorganisms9071508 article EN cc-by Microorganisms 2021-07-14

ABSTRACT Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections causing significant morbidity and mortality among children the elderly; two RSV vaccines monoclonal antibody have recently been approved. Thus, there an increasing need for detailed continuous genomic surveillance circulating in resource-rich resource-limited settings worldwide. However, robust, cost-effective methods whole genome sequencing from clinical samples that are amenable to...

10.1128/jcm.01111-23 article EN Journal of Clinical Microbiology 2024-02-26

Using participatory, virologic, and wastewater surveillance systems, we estimated when to what extent reported data of adult COVID-19 cases underestimated incidence in Germany. We also examined how case underestimation evolved over time. Our findings highlight community-based systems can complement official notification for respiratory disease dynamics.

10.3201/eid3009.240640 article EN cc-by Emerging infectious diseases 2024-08-23
Coming Soon ...